Advanced BioScience Laboratories

ABL’s animal facilities are located in Rockville, Maryland. We currently operate a ~35,000 square-foot Animal Biosafety Level 2/3 (ABSL-2/3) containment area. ABL's animal facility is USDA-registered and is accredited by the American Association for the Accreditation of Laboratory Animal Care International (AAALAC), an association widely recognized for its standards of excellence in laboratory animal care. As an accredited organization, ABL complies with all policies of the "Guide for the Care and Use of Laboratory Animals," DHHS (NIH 85-23), Animal Welfare (DHHS-TN 73-2) the NIH Manual Issuance 4206 and 6000-3-4-58, "Responsibility for Care and Use of Animals CDC/NIH 4th edition”, “Biosafety in Microbiological and Biomedical Laboratories,” and Public Health Service Policy on Humane Care and Use of Laboratory Animals. ABL has a Category 1 assurance from OLAW of the Public Health Service.

Non human primates:
ABL has been performing vital non human primate (NHP) studies for government and commercial clients for over 30 years. We have a wealth of experience and capabilties to help clients answer their research questions and aid with candidate selection. We regularly perform both small and large client studies and are able to peform the necessary animal manipulations along with a majority of the associated Efficacy and Potency Testing. All NHPs go through a rigorous prescreening before they arrive at ABL’s location and are tested again during our mandatory 60-day quarantine to ensure the animals meet the requirements. The testing includes a viral panel (e.g., SIV, SRV, STLV, measles and Herpes B virus) within 30 days prior to shipment to ABL’s animal facility which is preformed again during the quarantine period.

Rodent and Rabbits:
ABL has been performing vital rabbit and rodent studies for government and commercial clients for over 30 years. We have a wealth of experience and capabilties that we are able to bring to bear to help clients answer their research questions and aid with candidate selection. We regularly perform both small and large studies for clients, and are unique in that we are able to not only perform the complex animal manipulations and sample collections but also can do the associated testing and analysis. Routes of Administration:

VIRAL ANTIGENS AND PROTEINS
ABL has the capability to produce highly pure native envelope and gag HIV-1 and SIV antigens. These native proteins are purified from the conditioned media of chronically infected Human T-cell lines using immunoaffinity chromatography. They are purified by reverse phase chromatography resulting in purities greater than 95%. In addition, we offer a biologically active recombinant HIV-1 Tat protein which is produced in E. coli and purified using heparin sepharose and reverse phase chromatography. Tat is greater than 95% pure and biologically active by an HIV-1 rescue assay.

Lymphoproliferation assay

PBMC and target cell based assays

Mammalian cell lines
Microbial cell lines
Insect cell lines
Adherent and suspension-based processes
Adaptation to animal origin-free media
Up to 500 vials per bank

Quantify secreted cytokines

ELISPOT – mouse and rhesus samples

Examine memory T-cell responses by FACS
FACS analysis to quantitate or determine production of IFN-gamma, TNF-alpha, IL-2, IL-4, IL-5, IL-6, IL-10, and other cytokines
Cell surface antibody binding by FACS

ABL’s animal facilities are located in Rockville, Maryland. We currently operate a ~35,000 square-foot Animal Biosafety Level 2/3 (ABSL-2/3) containment area. ABL's animal facility is USDA-registered and is accredited by the American Association for the Accreditation of Laboratory Animal Care International (AAALAC), an association widely recognized for its standards of excellence in laboratory animal care. As an accredited organization, ABL complies with all policies of the "Guide for the Care and Use of Laboratory Animals," DHHS (NIH 85-23), Animal Welfare (DHHS-TN 73-2) the NIH Manual Issuance 4206 and 6000-3-4-58, "Responsibility for Care and Use of Animals CDC/NIH 4th edition”, “Biosafety in Microbiological and Biomedical Laboratories,” and Public Health Service Policy on Humane Care and Use of Laboratory Animals. ABL has a Category 1 assurance from OLAW of the Public Health Service.

Non human primates:
ABL has been performing vital non human primate (NHP) studies for government and commercial clients for over 30 years. We have a wealth of experience and capabilties to help clients answer their research questions and aid with candidate selection. We regularly perform both small and large client studies and are able to peform the necessary animal manipulations along with a majority of the associated Efficacy and Potency Testing. All NHPs go through a rigorous prescreening before they arrive at ABL’s location and are tested again during our mandatory 60-day quarantine to ensure the animals meet the requirements. The testing includes a viral panel (e.g., SIV, SRV, STLV, measles and Herpes B virus) within 30 days prior to shipment to ABL’s animal facility which is preformed again during the quarantine period.

ABL regularly conducts upstream and downstream development work for our clients - an essential step towards efficient design of cGMP-compliant manufacturing. We draw on our scientific, manufacturing and quality expertise to design production processes that optimize product yields and minimize regulatory risk. Our technical approach incorporates the use of disposal, single use technologies to maximize flexible manufacturing capacities, reduce clean room turn around, and accelerate time to clinic.

ABL’s animal facilities are located in Rockville, Maryland. We currently operate a ~35,000 square-foot Animal Biosafety Level 2/3 (ABSL-2/3) containment area. ABL's animal facility is USDA-registered and is accredited by the American Association for the Accreditation of Laboratory Animal Care International (AAALAC), an association widely recognized for its standards of excellence in laboratory animal care. As an accredited organization, ABL complies with all policies of the "Guide for the Care and Use of Laboratory Animals," DHHS (NIH 85-23), Animal Welfare (DHHS-TN 73-2) the NIH Manual Issuance 4206 and 6000-3-4-58, "Responsibility for Care and Use of Animals CDC/NIH 4th edition”, “Biosafety in Microbiological and Biomedical Laboratories,” and Public Health Service Policy on Humane Care and Use of Laboratory Animals. ABL has a Category 1 assurance from OLAW of the Public Health Service.

Rodent and Rabbits:
ABL has been performing vital rabbit and rodent studies for government and commercial clients for over 30 years. We have a wealth of experience and capabilties that we are able to bring to bear to help clients answer their research questions and aid with candidate selection. We regularly perform both small and large studies for clients, and are unique in that we are able to not only perform the complex animal manipulations and sample collections but also can do the associated testing and analysis. Routes of Administration:

ABL has developed high affinity murine monoclonal antibodies (Mabs) against numerous retroviral proteins, including the envelope proteins gp120 and gp160. These antibodies are purified from ascites fluid or the conditioned media from hybridoma cultures using protein A sepharose. The resulting Mabs are highly reactive and specific.